Answers are grounded in this paper and cite their sources.
Although exacerbations become more frequent and more severe as COPD progresses, the rate at which they occur appears to reflect an independent susceptibility phenotype. This has implications for the targeting of exacerbation-prevention strategies across the spectrum of disease severity. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT00292552.)
No takes yet. Share an insight, caveat, or question.
Hurst et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: